Where fantasy meets reality
Antoni Homs, a postdoc in the Nanobioengineering group, did his bit for the public understanding of science this week by participating in two events in collaboration with the Centre Cultural Sant Josep in Hospitalet.
Antoni Homs, a postdoc in the Nanobioengineering group, did his bit for the public understanding of science this week by participating in two events in collaboration with the Centre Cultural Sant Josep in Hospitalet.
An article by IBEC associate director Josep Samitier, ‘Nanomedicina: nanotecnologías aplicadas a la salud’ appears in the latest edition of SEBBM, a periodical published by the Sociedad Española de Bioquímica y Biología Molecular.
IBEC group leader Xavier Trepat is the subject of the latest edition of Destacamus, a bimonthly magazine published by Biopol’H which profiles researchers.
In its June edition, El Global, the most prominent journal on the pharmaceutical sector in Spain, features a news item on the IBEC-led alliance BioNanoMed Catalunya, which aims to bring together researchers, hospitals and companies working in nanomedicine.
On Monday 6 June, IBEC will present its activities to biomedical researchers and clinicians from IDIBELL (the Bellvitge Biomedical Research Institute) to kick off an official collaboration agreement between the two institutes.
In today’s edition of Catalan newspaper Ara, IBEC associate director Josep Samitier is interviewed for a full-page feature. In it, he tells journalist Joan García about the history and goals of IBEC, its successes and the challenges it faces.
Biomechanics and mechanobiology group leader Damien Lacroix has been awarded a prestigious European Research Council (ERC) Starting Grant for his research on finite element simulations of mechanobiology in tissue engineering.
Processes like tissue regeneration and cancer metastasis rely on groups of cells moving long distances without losing their cohesiveness, but how they do this has remained unknown. Now researchers from the Institute for Bioengineering of Catalonia (IBEC) and Harvard University have solved the mystery and unveiled a brand new phenomenon in biology.
A press conference to present BioNanoMed Catalunya, the IBEC-led alliance created to promote nanotechnology applied to healthcare and biotechnology, was held on Friday at the Museu Colet in Barcelona.